eIF5A isoforms and cancer: two brothers for two functions?
- 733 Downloads
Eukaryotic translation initiation factor 5A (eIF5A) is the only cellular protein that contains the unusual amino acid hypusine [N ε-(4-amino-2-hydroxybutyl)lysine]. The role of hypusine formation in the eIF5A protein in the regulation of cell proliferation and apoptosis is addressed in the present review. Moreover, vertebrates carry two genes that encode two eIF5A isoforms, eIF5A-1 and eIF5A-2, which, in humans, are 84% identical. However, the biological functions of these two isoforms may be significantly different. In fact, eIF5A-1 is demonstrable in most cells of different histogenesis, whereas eIF5A-2 protein is detectable only in certain human cancer cells or tissues, suggesting its role as a potential oncogene. In this review we focus our attention on the involvement of eIF5A-1 in the triggering of an apoptotic program and in the regulation of cell proliferation. In addition, the potential oncogenic role and prognostic significance of eIF5A-2 in the prediction of the survival of cancer patients is described. eIF5A-1 and/or the eIF5A-2 isoform may serve as a new molecular diagnostic or prognostic marker or as a molecular target for anti-cancer therapy.
KeywordseIF5A isoform Hypusine Tissue transglutaminase Cancer Apoptosis Prognostic markers Hypusine synthesis inhibitors
This paper is dedicated to the memory of Dr. J.E. Folk (Oct 29, 1925–Dec 27, 2010). In addition to his pioneering work on the mechanism of transglutaminase, he and his colleagues discovered the hypusine modification pathway. The research was supported in part by the Intramural Research Program of National Institute of Dental and Craniofacial Research (NIDCR).
- Balabanov S, Gontarewicz A, Ziegler P, Hartmann U, Kammer W, Copland M, Brassat U, Priemer M, Hauber I, Wilhelm T, Schwarz G, Kanz L, Bokemeyer C, Hauber J, Holyoake TL, Nordheim A, Bru¨mmendorf TH (2007) Hypusination of eukaryotic initiation factor 5A(eIF5A): a novel therapeutic target in BCR-ABL–positive leukemias identified by a proteomics approach. Blood 109(4):1701–1711PubMedCrossRefGoogle Scholar
- Caraglia M, Passeggio A, Beninati S, Leardi A, Nicolini L, Improta S, Pinto A, Bianco AR, Tagliaferri P, Abbruzzese A (1997) Interferon alpha2 recombinant and epidermal growth factor modulate proliferation and hypusine synthesis in human epidermoid cancer KB cells. Biochem J 324:737–741PubMedGoogle Scholar
- Caraglia M, Marra M, Giuberti G, D’Alessandro AM, Baldi A, Tassone P, Venuta S, Tagliaferri P, Abbruzzese A (2003) The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells. J Biochem (Tokyo) 133:757–765CrossRefGoogle Scholar
- Hanauske-Abel HM, Heller D, Wolff EC, Hameed M, Clement PMJ, Park MH et al (2002) Eukaryotic translation initiation factor 5A, an emerging target for cytostatic compounds, localizes to proliferative regions in human tissue. Cancer Epidemiol Biomarkers Prev 11:1145sGoogle Scholar
- Maier B, Ogihara T, Trace AP, Tersey SA, Robbins RD, Chakrabarti SK, Nunemaker CS, Stull ND, Taylor CA, Thompson JE, Dondero RS, Lewis EC, Dinarello CA, Nadler JL, Mirmira RG (2010) The unique hypusine modification of eIF5A promotes islet β cell inflammation and dysfunction in mice. J Clin Invest 120:2156–2170PubMedCrossRefGoogle Scholar
- Nishimura K, Lee SB, Park JH, Park MH (2011) Essential role of eIF5A-1 and deoxyhypusine synthase in mouse embryonic development. Amino Acids (in press)Google Scholar
- Park MH, Wolff EC, Folk JE (1993) Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Biofactors 4(2):95–104Google Scholar
- Ruhl M, Himmelspach M, Bahr GM, Hammerschmid F, Jaksche H, Wolff B, Aschauer H, Farrington GK, Probst H, Bevec D, Hauber J (1993) Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J Cell Biol 123:1309–1320PubMedCrossRefGoogle Scholar
- Taylor CA, Senchyna M, Flanagan J, Joyce EM, Cliche DO, Boone AN, Culp-Stewart S, Thompson JE (2004) Role of eIF5A in TNF-alpha-mediated apoptosis of lamina cribrosa cells, Invest. Ophthalmol. Visual Sci 45:3568–3576Google Scholar
- Taylor CA, Sun Z, Cliché DO, Ming H, Eshaque B, Jin S, Hopkins MT, Thai B, Thompson JE (2007) Eukaryotic translation initiation factor 5A induces apoptosis in colon cancer cells and associates with the nucleus in response to tumour necrosis factor a signaling. Exp Cell Res 313:437–449PubMedCrossRefGoogle Scholar
- Yang GF, Xie D, Liu JH, Luo JH, Li LJ, Hua WF, Wu HM, Kung HF, Zeng YX, Guan XY (2009) Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma. Gynecol Oncol 112:314–318PubMedCrossRefGoogle Scholar
- Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, Ma B, Zender P, Kubicka S, Luk JM, Schirmacher P, McCombie RW, Wigler M, Hicks J, Hannon GJ, Powers S, Lowe SW (2008) An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 135:852–864PubMedCrossRefGoogle Scholar